Supporting Table S4

Supporting Table S4

<p> Supporting Table S4: </p><p>Term Count % P-Value Genes Pop Pop Fold Hits Total Enrichment rno04512:ECM- 20 1.9 3.56E-08 COL4A1,COL3A1,ITGA1,ITGA3 81 5590 4.540286 receptor interaction ,ITGA4,SDC4,COL5A3,COL5A2 ,COL5A1,HMMR,CD47,ITGA6,I TGB6,COL6A3,COL6A2,COL6A 1,LAMC2,TNN,THBS2,SPP1 rno04510:Focal 29 2.7 1.58E-06 CAV2,CAV1,PDGFB,COL3A1,P 195 5590 2.734649 adhesion XN,MYL9,VCL,ITGB6,COL6A3, SOS2,COL6A2,COL6A1,TNN,S HC2,THBS2,SPP1,COL4A1,PIK 3CB,ITGA1,MYLPF,PRKCG,IT GA3,ITGA4,VAV2,COL5A3,CO L5A2,COL5A1,ITGA6,LAMC2 rno05410:Hypertrophic 15 1.4 1.41E-04 CACNA2D1,TGFB3,ITGA1,CAC 84 5590 3.2836 cardiomyopathy (HCM) NB1,CACNB2,ITGA3,ITGA4,CA CNG1,CACNA2D2,TNNT2,ITG A6,SGCG,ITGB6,PRKAA2,SGC B rno05414:Dilated 15 1.4 3.00E-04 CACNA2D1,TGFB3,ITGA1,CAC 90 5590 3.064693 cardiomyopathy NB1,CACNB2,ITGA3,ITGA4,CA CNG1,CACNA2D2,TNNT2,ITG A6,SGCG,PLN,ITGB6,SGCB rno05412:Arrhythmoge 13 1.2 5.47E-04 CACNA2D1,ITGA1,CACNB1,C 74 5590 3.230352 nic right ventricular ACNB2,ITGA3,ITGA4,CACNG1, cardiomyopathy CACNA2D2,ITGA6,SGCG,PKP (ARVC) 2,ITGB6,SGCB rno04810:Regulation 24 2.2 8.41E-04 FGFR3,PDGFB,PIK3CB,LIMK1, 209 5590 2.111559 of actin cytoskeleton BAIAP2,FGF11,ITGA1,MYLPF,I TGA3,FGF13,ITGA4,VAV2,IQG AP1,PXN,MYL9,VCL,CHRM3,IT GA6,TIAM1,CHRM1,ITGB6,SO S2,MYH14,CD14 rno05200:Pathways in 31 2.9 0.00177 FGFR3,PDGFB,STAT5A,FGF1 317 5590 1.798211 cancer 1,TGFB3,FGF13,WNT4,CASP3, CDKN2B,SOS2,TGFA,FAS,WN T6,MYC,BMP4,BMP2,HSP90A A1,COL4A1,RALBP1,PIK3CB,R XRA,TGFBR2,FZD1,BRCA2,PR KCG,ITGA3,FZD2,RASSF5,ITG A6,LAMC2,TRA1 rno04610:Complement 11 1.0 0.004122 A2M,FGG,CD55,MASP1,F3,CD 70 5590 2.889568 and coagulation 59,SERPINE1,CFH,C1R,C1S,C cascades FD rno04010:MAPK 26 2.4 0.004628 FGFR3,PDGFB,TGFB3,FGF11, 266 5590 1.797339 signaling pathway CACNB1,CACNB2,FGF13,TNF RSF1A,CASP3,RASGRP3,MAP 3K1,SOS2,NFATC4,FAS,MYC, CCDC88B,CACNA2D1,TGFBR 2,PRKCG,CACNG1,CACNA2D 2,DUSP5,DUSP1,CACNA1G,G ADD45A,CD14 rno04360:Axon 15 1.4 0.008422 PLXNA2,LIMK1,EFNB2,EPHB3, 127 5590 2.17183 guidance EPHA2,SLIT3,EPHA4,SEMA6A, EPHA7,SEMA6C,UNC5B,SEM A3E,SRGAP3,NFATC4,UNC5C rno04670:Leukocyte 13 1.2 0.021172 PIK3CB,MYLPF,PRKCG,ITGA4 115 5590 2.078661 transendothelial ,VAV2,PXN,VCL,CLDN15,MYL9 migration ,VCAM1,RASSF5,PTK2B,RAP GEF3 rno03320:PPAR 9 0.8 0.037036 CPT1C,LPL,SLC27A1,ACADM, 71 5590 2.330893 signaling pathway RXRA,SCD,ACSL3,CPT1A,AC OX3 rno04530:Tight 13 1.2 0.048366 PARD6B,PARD3,VAPA,MYH2, 130 5590 1.838816 junction MYLPF,PRKCG,TJAP1,CLDN1 5,MYL9,EPB4.1L1,MYH14,PPP 2R2B,MYH7B rno04640:Hematopoiet 9 0.8 0.059172 CD55,ITGA6,CD3E,CD59,IL4R 78 5590 2.121711 ic cell lineage A,ITGA1,ITGA3,ITGA4,CD14 rno05223:Non-small 7 0.6 0.060477 RASSF5,PIK3CB,RXRA,SOS2, 52 5590 2.475329 cell lung cancer TGFA,PRKCG,FOXO3 rno04115:p53 8 0.7 0.064783 STEAP3,CASP3,CCNB2,SERPI 66 5590 2.228868 signaling pathway NE1,FAS,PMAIP1,CCNG2,GAD D45A rno04920:Adipocytokin 8 0.7 0.069155 CPT1C,TNFRSF1A,SOCS3,RX 67 5590 2.195601 e signaling pathway RA,PRKAA2,ACSL3,IRS1,CPT1 A rno00071:Fatty acid 6 0.5 0.074727 CPT1C,ACADM,ACSL3,DCI,CP 42 5590 2.62688 metabolism T1A,ACOX3 rno04650:Natural killer 10 0.9 0.091204 CASP3,PTK2B,PIK3CB,SOS2,L 100 5590 1.838816 cell mediated OC498276,NFATC4,PRKCG,FA cytotoxicity S,VAV2,SHC2 rno04350:TGF-beta 9 0.8 0.092978 BMP4,BMP2,CDKN2B,GDF6,S 86 5590 1.924342 signaling pathway MAD6,TGFBR2,TGFB3,THBS2, MYC rno05416:Viral 9 0.8 0.097851 CAV1,CD55,CASP3,SGCG,MY 87 5590 1.902223 myocarditis H2,MYH14,CXADR,MYH7B,SG CB</p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us